Skip Ribbon Commands
Skip to main content


6.1 Use

General Population

  • There are no publicly available estimates of inhalant use for Ontario adults based on surveys representative of the adult population.

Youth and Young Adults

  • 2.8% of Ontario students (grades 7-12) reported inhalant use in the past year. Rates have decreased from 3.4% in 2013 and were highest (6.2%) among students in grade 7 according to the 2015 OSDUHS (n=10,426).3
  • 2% of Ontario high school students (grade 7-12) reported (past-year) glue, gasoline, solvent or salvia use to get high in the 2012-13 Youth Smoking Survey (Ontario sub-sample n=7,018).94
  • Reported lifetime use rates were 1.0% for inhalants among Ontario postsecondary students, with 0.2% reporting past-month use, according to the 2013 NCHA Canadian survey (Ontario sub-sample n=16,123).6

Special Populations

Indigenous Populations

  • Less than 0.5% of (n=1,425) First Nations adults (aged 18+) used inhalants (past-year) according to the 2008-10 Regional Health Survey representative of Ontario First Nation adults living on reserve.8,9

Racialized Populations

  • There are no publicly available provincial data on inhalant use among racialized populations.

Homeless and Street-Involved Populations

  • 3% of homeless adults in Toronto reported using inhalants (past two years) among a stratified random sample (n=1,191) in 2004-05.12 Among Toronto-based homeless adults, 2% used solvents and other inhalants regularly (+3 times/week) in the past year, based on a random sample of (n=368) homeless adults in Toronto (2006-07).11
  • One in five (20%) males and 13% of females reported popper use (past six months) among a convenience sample of (n=100) homeless youth (aged 16-24) who use substances surveyed in Toronto (Drugs, Homelessness and Health survey, 2008-09).14

Pregnant and Parenting Women

  • There are no publicly-available provincial data on women's inhalant use during pregnancy.

Injection Drug Users

Recreational Drug Users

6.2 Interventions


  • 0.3% (327 admissions) of patients presenting to Ontario publicly-funded substance abuse treatment reported glue and inhalants as a problem substance upon admission in 2012-13; a decrease of 50.2% (from 657 admissions) in 2007-08, according to data obtained from DATIS.25